application-notes
Regulatory agencies have made recommendations on when and how to identify and characterize drug metabolites to evaluate their non-clinical toxicity. Frontage has developed an approach that integrates a series of in vitro and in vivo assays to demonstrate due diligence in meeting MIST regulatory expectations.
Register to gain access to gated resources.
"*" indicates required fields
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.